• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Neoadjuvant Chemotherapy in Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

作者信息

Xu Xianyun, Xie Qiongjun, Huang Haijin, Peng Wei, Liu Jianping, Huang Wenzhen, Li Xiaobo, Zhong Jiacheng, Ma Liangwen, Liu Qian

机构信息

Basic Medical School, Gannan Medical University, Ganzhou, Jiangxi, People's Republic of China.

Jiangxi Provincial Clinical Research Center for Vascular Anomalies, the First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, People's Republic of China.

出版信息

Am J Ther. 2021;28(1):e150-e156. doi: 10.1097/MJT.0000000000001002.

DOI:10.1097/MJT.0000000000001002
PMID:33369918
Abstract
摘要

相似文献

1
Neoadjuvant Chemotherapy in Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.乳腺癌新辅助化疗：随机对照试验的系统评价与荟萃分析
Am J Ther. 2021;28(1):e150-e156. doi: 10.1097/MJT.0000000000001002.
2
Neoadjuvant chemotherapy.新辅助化疗
Breast Dis. 2004;21:23-31. doi: 10.3233/bd-2004-21104.
3
[Adjuvant chemotherapy in breast cancer. New strategies].
Tumori. 2000 Nov-Dec;86(6 Suppl 1):S9-10. doi: 10.1177/03008916000866S103.
4
Tumor-infiltrating lymphocytes in patients with HER2-positive breast cancer treated with neoadjuvant chemotherapy plus trastuzumab, lapatinib or their combination: A meta-analysis of randomized controlled trials.曲妥珠单抗、拉帕替尼或联合治疗新辅助化疗治疗 HER2 阳性乳腺癌患者的肿瘤浸润淋巴细胞：一项随机对照试验的荟萃分析。
Cancer Treat Rev. 2017 Jun;57:8-15. doi: 10.1016/j.ctrv.2017.04.005. Epub 2017 May 2.
5
Neoadjuvant chemotherapy for operable breast cancer.可手术乳腺癌的新辅助化疗
Oncology (Williston Park). 2002 Jul;16(7):871-84, 889; discussion 889-90, 892-4, 897-8.
6
Dual Block with Lapatinib and Trastuzumab Versus Single-Agent Trastuzumab Combined with Chemotherapy as Neoadjuvant Treatment of HER2-Positive Breast Cancer: A Meta-analysis of Randomized Trials.曲妥珠单抗联合拉帕替尼与曲妥珠单抗单药联合化疗作为人表皮生长因子受体 2 阳性乳腺癌新辅助治疗的对比：一项随机试验的荟萃分析。
Clin Cancer Res. 2016 Sep 15;22(18):4594-603. doi: 10.1158/1078-0432.CCR-15-1881. Epub 2016 May 2.
7
Neoadjuvant chemotherapy and concomitant trastuzumab in breast cancer: a pooled analysis of two randomized trials.新辅助化疗联合曲妥珠单抗治疗乳腺癌：两项随机试验的汇总分析。
Anticancer Drugs. 2011 Feb;22(2):128-35. doi: 10.1097/cad.0b013e32834120aa.
8
Re: Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis.关于：乳腺癌新辅助治疗与辅助全身治疗的荟萃分析。
J Natl Cancer Inst. 2005 Jun 1;97(11):858; author reply 858-9. doi: 10.1093/jnci/dji147.
9
[Neoadjuvant Chemotherapy in breast cancer].[乳腺癌的新辅助化疗]
Nihon Rinsho. 2006 Mar;64(3):536-9.
10
Oxaliplatin/fluorouracil-based adjuvant chemotherapy for locally advanced rectal cancer after neoadjuvant chemoradiotherapy and surgery: a systematic review and meta-analysis of randomized controlled trials.新辅助放化疗和手术治疗局部进展期直肠癌后的奥沙利铂/氟尿嘧啶为基础的辅助化疗：随机对照试验的系统评价和荟萃分析。
Colorectal Dis. 2016 Aug;18(8):763-72. doi: 10.1111/codi.13381.